BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17336449)

  • 1. Collecting duct renal cell carcinoma: a matched analysis of 41 cases.
    Karakiewicz PI; Trinh QD; Rioux-Leclercq N; de la Taille A; Novara G; Tostain J; Cindolo L; Ficarra V; Artibani W; Schips L; Zigeuner R; Mulders PF; Lechevallier E; Coulange C; Valeri A; Descotes JL; Rambeaud JJ; Abbou CC; Lang H; Jacqmin D; Mejean A; Patard JJ
    Eur Urol; 2007 Oct; 52(4):1140-5. PubMed ID: 17336449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unclassified renal cell carcinoma: an analysis of 85 cases.
    Karakiewicz PI; Hutterer GC; Trinh QD; Pantuck AJ; Klatte T; Lam JS; Guille F; de La Taille A; Novara G; Tostain J; Cindolo L; Ficarra V; Schips L; Zigeuner R; Mulders PF; Chautard D; Lechevallier E; Valeri A; Descotes JL; Lang H; Soulie M; Ferriere JM; Pfister C; Mejean A; Belldegrun AS; Patard JJ
    BJU Int; 2007 Oct; 100(4):802-8. PubMed ID: 17822461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics.
    Jeldres C; Patard JJ; Capitanio U; Perrotte P; Suardi N; Crepel M; Ficarra V; Cindolo L; de La Taille A; Tostain J; Pfister C; Albouy B; Colombel M; Méjean A; Lang H; Jacqmin D; Bernhard JC; Ferrière JM; Bensalah K; Karakiewicz PI
    Urology; 2009 Jun; 73(6):1300-5. PubMed ID: 19376568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Swanson DA; Wood CG
    Cancer; 2008 Apr; 112(7):1480-8. PubMed ID: 18240184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathobiology and prognosis of chromophobe renal cell carcinoma.
    Klatte T; Han KR; Said JW; Böhm M; Allhoff EP; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    Urol Oncol; 2008; 26(6):604-9. PubMed ID: 18367104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma.
    Klatte T; Chung J; Leppert JT; Lam JS; Pantuck AJ; Figlin RA; Belldegrun AS
    BJU Int; 2007 Apr; 99(4):821-4. PubMed ID: 17244281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma.
    Hutterer GC; Patard JJ; Colombel M; Belldegrun AS; Pfister C; Guille F; Artibani W; Montorsi F; Pantuck AJ; Karakiewicz PI
    Cancer; 2007 Dec; 110(11):2428-33. PubMed ID: 17941033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a place for radical nephrectomy in the presence of metastatic collecting duct (Bellini) carcinoma?
    Méjean A; Rouprêt M; Larousserie F; Hopirtean V; Thiounn N; Dufour B
    J Urol; 2003 Apr; 169(4):1287-90. PubMed ID: 12629344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival.
    Karakiewicz PI; Trinh QD; Bhojani N; Bensalah K; Salomon L; de la Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Schips L; Zigeuner R; Mulders PF; Valeri A; Descotes JL; Mejean A; Patard JJ
    Eur Urol; 2007 Jun; 51(6):1616-24. PubMed ID: 17207909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma.
    Verhoest G; Avakian R; Bensalah K; Thuret R; Ficarra V; Artibani W; Tostain J; Guille F; Cindolo L; De La Taille A; Abbou CC; Salomon L; Rioux-Leclercq N; Patard JJ
    J Urol; 2009 Sep; 182(3):854-9. PubMed ID: 19616244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the involvement of the urinary collecting system in renal cell carcinoma.
    Terrone C; Cracco C; Guercio S; Bollito E; Poggio M; Scoffone C; Tarabuzzi R; Porpiglia F; Scarpa RM; Fontana D; Rocca Rossetti S
    Eur Urol; 2004 Oct; 46(4):472-6. PubMed ID: 15363563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic renal cell carcinoma: biology and clinical behavior.
    Han KR; Janzen NK; McWhorter VC; Kim HL; Pantuck AJ; Zisman A; Figlin RA; Dorey FJ; Said JW; Belldegrun AS
    Urol Oncol; 2004; 22(5):410-4. PubMed ID: 15464922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors.
    Salama ME; Guru K; Stricker H; Peterson E; Peabody J; Menon M; Amin MB; De Peralta-Venturina M
    J Urol; 2005 May; 173(5):1492-5. PubMed ID: 15821466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma.
    Verhoest G; Veillard D; Guillé F; De La Taille A; Salomon L; Abbou CC; Valéri A; Lechevallier E; Descotes JL; Lang H; Jacqmin D; Tostain J; Cindolo L; Ficarra V; Artibani W; Schips L; Zigeuner R; Mulders PF; Mejean A; Patard JJ
    Eur Urol; 2007 May; 51(5):1298-304; discussion 1304-5. PubMed ID: 17174023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients.
    Marszalek M; Meixl H; Polajnar M; Rauchenwald M; Jeschke K; Madersbacher S
    Eur Urol; 2009 May; 55(5):1171-8. PubMed ID: 19232819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrectomy improves the survival of patients with locally advanced renal cell carcinoma.
    Zini L; Perrotte P; Jeldres C; Capitanio U; Pharand D; Arjane P; Lapointe S; Montorsi F; Patard JJ; Karakiewicz PI
    BJU Int; 2008 Dec; 102(11):1610-4. PubMed ID: 18710442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collecting system invasion in renal cell carcinoma: impact on prognosis and future staging strategies.
    Palapattu GS; Pantuck AJ; Dorey F; Said JW; Figlin RA; Belldegrun AS
    J Urol; 2003 Sep; 170(3):768-72; discussion 772. PubMed ID: 12913694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
    Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
    Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model.
    May M; Ficarra V; Shariat SF; Zigeuner R; Chromecki T; Cindolo L; Burger M; Gunia S; Feciche B; Wenzl V; Aziz A; Chun F; Becker A; Pahernik S; Simeone C; Longo N; Zucchi A; Antonelli A; Mirone V; Stief C; Novara G; Brookman-May S; ;
    J Urol; 2013 Aug; 190(2):458-63. PubMed ID: 23434943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
    Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
    J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.